Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Choi VW"'
Autor:
Chiarle R, Zhang Y, Frock RL, Lewis SM, Molinie B, Ho YJ, Myers DR, Choi VW, Compagno M, Malkin DJ, Neuberg D, Monti S, Giallourakis CC, Gostissa M, Alt FW.
Publikováno v:
Cell.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=erc_________::8704b9aeaccd73cc1cb2a51a074a455e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Chen N; Takeda Development Center Americas, Inc., Cambridge, MA, USA., Ehmann DE; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Pretzel Therapeutics, Waltham, MA, USA., Crooker R; Takeda Development Center Americas, Inc., Cambridge, MA, USA., Derakhchan K; Takeda Development Center Americas, Inc., Cambridge, MA, USA., Fang X; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Asklepios BioPharmaceutical (AskBio), Research Triangle Park, NC, USA., Felice B; Takeda Development Center Americas, Inc., Cambridge, MA, USA., Galbreath EJ; Takeda Development Center Americas, Inc., Cambridge, MA, USA., Glaus C; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Bayer HealthCare Pharmaceuticals, Cambridge, MA, USA., Gu H; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; PTM Bio LLC, Hangzhou, Zhejiang, China., Huang Y; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Editas Medicine, Cambridge, MA, USA., Li C; Takeda Development Center Americas, Inc., Cambridge, MA, USA., Li X; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Ultragenyx, Cambridge, MA, USA., Liu N; Takeda Development Center Americas, Inc., Cambridge, MA, USA., Palmieri K; Takeda Development Center Americas, Inc., Cambridge, MA, USA., Simic D; Takeda Development Center Americas, Inc., Cambridge, MA, USA.; Astellas Gene Therapies, San Francisco, CA, USA., Sypek J; Takeda Development Center Americas, Inc., Cambridge, MA, USA., Thompson S; Takeda Development Center Americas, Inc., Cambridge, MA, USA., Winkelmann CT; Takeda Development Center Americas, Inc., Cambridge, MA, USA., Choi VW; Takeda Development Center Americas, Inc., Cambridge, MA, USA.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2023 Mar 28; Vol. 29, pp. 286-302. Date of Electronic Publication: 2023 Mar 28 (Print Publication: 2023).
Autor:
Sorrentino NC; Telethon Institute of Genetics and Medicine, Via Campi Flegrei 34, Pozzuoli, Naples, Italy., Cacace V; Telethon Institute of Genetics and Medicine, Via Campi Flegrei 34, Pozzuoli, Naples, Italy., De Risi M; Telethon Institute of Genetics and Medicine, Via Campi Flegrei 34, Pozzuoli, Naples, Italy., Maffia V; Telethon Institute of Genetics and Medicine, Via Campi Flegrei 34, Pozzuoli, Naples, Italy., Strollo S; Telethon Institute of Genetics and Medicine, Via Campi Flegrei 34, Pozzuoli, Naples, Italy., Tedesco N; Telethon Institute of Genetics and Medicine, Via Campi Flegrei 34, Pozzuoli, Naples, Italy., Nusco E; Telethon Institute of Genetics and Medicine, Via Campi Flegrei 34, Pozzuoli, Naples, Italy., Romagnoli N; Department of Veterinary Medical Sciences, University of Bologna, Via Tolara di Sopra 50, Ozzano dell'Emilia, Bologna, Italy., Ventrella D; Department of Veterinary Medical Sciences, University of Bologna, Via Tolara di Sopra 50, Ozzano dell'Emilia, Bologna, Italy., Huang Y; Takeda Pharmaceuticals, Cambridge, MA, USA., Liu N; Takeda Pharmaceuticals, Cambridge, MA, USA., Kalled SL; Takeda Pharmaceuticals, Cambridge, MA, USA., Choi VW; Takeda Pharmaceuticals, Cambridge, MA, USA., De Leonibus E; Telethon Institute of Genetics and Medicine, Via Campi Flegrei 34, Pozzuoli, Naples, Italy.; Institute of Cellular Biology and Neurobiology (IBCN), National Research Council (CNR), Via Ramarini 32, Monterotondo, Rome, Italy., Fraldi A; Telethon Institute of Genetics and Medicine, Via Campi Flegrei 34, Pozzuoli, Naples, Italy.; Department of Translational Medicine, University of Naples 'Federico II,' Naples, Italy.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2019 Oct 28; Vol. 15, pp. 333-342. Date of Electronic Publication: 2019 Oct 28 (Print Publication: 2019).
Autor:
MacLachlan TK; Preclinical Safety, Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Milton MN; Pharmacokinetic Sciences, Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Turner O; Preclinical Safety, Novartis Institutes for BioMedical Research, East Hanover, NJ, USA., Tukov F; Preclinical Safety, Novartis Institutes for BioMedical Research, East Hanover, NJ, USA., Choi VW; Ophthalmology Research, Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Penraat J; Preclinical Safety, Novartis Institutes for BioMedical Research, East Hanover, NJ, USA., Delmotte MH; Preclinical Safety, Novartis Institutes for BioMedical Research, Basel, Switzerland., Michaut L; Pharmacokinetic Sciences, Novartis Institutes for BioMedical Research, Basel, Switzerland., Jaffee BD; Ophthalmology Research, Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Bigelow CE; Ophthalmology Research, Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2017 Dec 22; Vol. 8, pp. 105-120. Date of Electronic Publication: 2017 Dec 22 (Print Publication: 2018).
Autor:
Choi VW; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Bigelow CE; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., McGee TL; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Gujar AN; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Li H; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Hanks SM; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Vrouvlianis J; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Maker M; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Leehy B; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Zhang Y; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Aranda J; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Bounoutas G; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Demirs JT; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Yang J; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Ornberg R; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Fort Worth, Texas, USA., Wang Y; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Fort Worth, Texas, USA., Martin W; Preclinical Safety, Alcon , Fort Worth, Texas, USA., Stout KR; Preclinical Safety, Alcon , Fort Worth, Texas, USA., Argentieri G; Preclinical Safety, Novartis Institutes for BioMedical Research , East Hanover, New Jersey, USA., Grosenstein P; Preclinical Safety, Novartis Institutes for BioMedical Research , East Hanover, New Jersey, USA., Diaz D; Preclinical Safety, Novartis Institutes for BioMedical Research , East Hanover, New Jersey, USA., Turner O; Preclinical Safety, Novartis Institutes for BioMedical Research , East Hanover, New Jersey, USA., Jaffee BD; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Police SR; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Dryja TP; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2015 Jul 08; Vol. 2, pp. 15022. Date of Electronic Publication: 2015 Jul 08 (Print Publication: 2015).
Autor:
Choi VW; Department of Physics and Materials Science, City University of Hong Kong, Tat Chee Avenue, Kowloon Tong, Hong Kong., Yu KN; Department of Physics and Materials Science, City University of Hong Kong, Tat Chee Avenue, Kowloon Tong, Hong Kong; State Key Laboratory in Marine Pollution, City University of Hong Kong, Tat Chee Avenue, Kowloon Tong, Hong Kong. Electronic address: peter.yu@cityu.edu.hk.
Publikováno v:
Cancer letters [Cancer Lett] 2015 Jan 01; Vol. 356 (1), pp. 91-104. Date of Electronic Publication: 2013 Oct 28.